Analysis: Expect no let-up in threat to pharma jobs in Ireland under either Biden or Trump

Mr Biden's plan to undo part of the Trump tax cuts and hike the headline US corporate tax rate to 28% from 21% is unlikely to go ahead, writes Eamon Quinn.

The Pfizer plant in Dun Laoghaire. Picture: Sasko Lazarov/RollingNews.ie

There’s no hiding from the fact that the re-election of Donald Trump would be the worst of the two outcomes threatening prosperity in Ireland, but there are huge risks to Irish pharmaceutical jobs no matter who secures the White House.

President Trump in a second term would likely be emboldened and double down on his pledge to get back American manufacturing jobs, which he claims have been stolen by foreign governments.